Publicaciones en las que colabora con Pablo Piñón Esteban (13)

2021

  1. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors

    Medicina Clinica, Vol. 156, Núm. 8, pp. 369-378

2014

  1. Long-term prognostic value of mitral regurgitation in patients with st-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 113, Núm. 6, pp. 907-912

2013

  1. Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: Insights from a cohort of 1391 patients

    European Heart Journal: Acute Cardiovascular Care, Vol. 2, Núm. 1, pp. 19-26

  2. Long-term prognostic benefit of field triage and direct transfer of patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 111, Núm. 12, pp. 1721-1726

2012

  1. Angioplastia primaria en el Área Norte de Galicia: cambios asistenciales y resultados tras la implantación del programa PROGALIAM

    Revista Espanola de Cardiologia, Vol. 65, Núm. 4, pp. 341-349

  2. Renal insufficiency and vascular complications after primary angioplasty via femoral route. Impact of vascular closure devices use

    Revista Espanola de Cardiologia, Vol. 65, Núm. 3, pp. 258-264

2011

  1. Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

    American Heart Journal, Vol. 161, Núm. 6, pp. 1207-1213

2010

  1. Prevalencia, causas y pronóstico de las «falsas alarmas» al laboratorio de hemodinámica en pacientes con sospecha de infarto de miocardio con elevación del segmento ST

    Revista Espanola de Cardiologia, Vol. 63, Núm. 5, pp. 518-527

2008

  1. Quinolone-related Achilles Tendinopathy in Heart Transplant Patients: Incidence and Risk Factors

    Journal of Heart and Lung Transplantation, Vol. 27, Núm. 1, pp. 46-51

2007

  1. Bone Fractures After Cardiac Transplantation

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2393-2396

2005

  1. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): Incidence, management, and the value of C4d for diagnosis

    American Journal of Transplantation, Vol. 5, Núm. 10, pp. 2560-2564

  2. Long-term results of heart transplant in recipients older and younger than 65 years: A comparative study of mortality, rejections, and neoplasia in a cohort of 445 patients

    Transplantation Proceedings

  3. Safety of statins when response is carefully monitored: A study of 336 heart recipients

    Transplantation Proceedings